BACKGROUND: Today, many kinds of surgery are being conducted without human assistants. Living donor nephrectomy (LDN) using video-assisted minilaparotomy surgery (VAM) has been performed by solo-surgeon using Unitrac® (Aesculap Surgical Instrument, Germany). We examined the results from VAM-solo-surgeon living donor nephrectomy (SLDN) and conventional VAM-human-assisted living donor nephrectomy (HLDN). METHODS:Between July 2007 and April 2008, 82 cases of VAM-LDN were performed by two surgeons. From these cases, we randomly assigned 35 cases to undergo solo-surgery (group I) and the other 47 cases to undergo surgery with one human assistant (group II). All VAM-LDN procedures were performed in the same manner. Only the roles of a first assistant were substituted by the Unitrac® in group I. We compared the perioperative and postoperative data, including operative time, estimated blood loss, and hospital stay, between the two groups. We also investigated cases that developed complications. RESULTS: There were no significant differences in the patient demographic data between the two groups (P > 0.05). The mean operative time was 201.9 ± 32.9 min in group I and 202.4 ± 48.3 min in group II (P = 0.954), whereas mean blood loss was 209.7 ± 167.3 ml in group I and 179.6 ± 87.8 ml in group II (P = 0.294). Postoperative hospital stay were 5.4 ± 1.1 days in group I and 5.5 ± 1.6 days in group II (P = 0.813). The incidence of perioperative complications was not significantly different between the two groups. CONCLUSIONS: Our study demonstrates that VAM-SLDN can be performed safely, is economically beneficial, and is comparable to VAM-HLDN in terms of postoperative outcomes.
RCT Entities:
BACKGROUND: Today, many kinds of surgery are being conducted without human assistants. Living donor nephrectomy (LDN) using video-assisted minilaparotomy surgery (VAM) has been performed by solo-surgeon using Unitrac® (Aesculap Surgical Instrument, Germany). We examined the results from VAM-solo-surgeon living donor nephrectomy (SLDN) and conventional VAM-human-assisted living donor nephrectomy (HLDN). METHODS: Between July 2007 and April 2008, 82 cases of VAM-LDN were performed by two surgeons. From these cases, we randomly assigned 35 cases to undergo solo-surgery (group I) and the other 47 cases to undergo surgery with one human assistant (group II). All VAM-LDN procedures were performed in the same manner. Only the roles of a first assistant were substituted by the Unitrac® in group I. We compared the perioperative and postoperative data, including operative time, estimated blood loss, and hospital stay, between the two groups. We also investigated cases that developed complications. RESULTS: There were no significant differences in the patient demographic data between the two groups (P > 0.05). The mean operative time was 201.9 ± 32.9 min in group I and 202.4 ± 48.3 min in group II (P = 0.954), whereas mean blood loss was 209.7 ± 167.3 ml in group I and 179.6 ± 87.8 ml in group II (P = 0.294). Postoperative hospital stay were 5.4 ± 1.1 days in group I and 5.5 ± 1.6 days in group II (P = 0.813). The incidence of perioperative complications was not significantly different between the two groups. CONCLUSIONS: Our study demonstrates that VAM-SLDN can be performed safely, is economically beneficial, and is comparable to VAM-HLDN in terms of postoperative outcomes.
Authors: Niels F M Kok; Eddy M M Adang; Birgitta M E Hansson; Ine M Dooper; Willem Weimar; Gert-Jan van der Wilt; Jan N M Ijzermans Journal: Transplantation Date: 2007-06-27 Impact factor: 4.939
Authors: K Tanoue; T Yasunaga; E Kobayashi; S Miyamoto; I Sakuma; T Dohi; K Konishi; S Yamaguchi; N Kinjo; K Takenaka; Y Maehara; M Hashizume Journal: Surg Endosc Date: 2005-12-06 Impact factor: 4.584
Authors: P Antiphon; A Hoznek; A Benyoussef; A de lataille; A Cicco; S Elard; M T Gettman; R Katz; D Vordos; L Salomon; D K Chopin; C C Abbou Journal: Urology Date: 2003-04 Impact factor: 2.649
Authors: Koon Ho Rha; Yu Seun Kim; Soon Il Kim; Young Joon Byun; Sung Joon Hong; Kiil Park; Seung Choul Yang Journal: Yonsei Med J Date: 2004-12-31 Impact factor: 2.759
Authors: Jee Soo Park; Hyun Kyu Ahn; Joonchae Na; Hyung Ho Lee; Young Eun Yoon; Min Gee Yoon; Woong Kyu Han Journal: Medicine (Baltimore) Date: 2018-04 Impact factor: 1.889